{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-130002","form_type":"8-K","ticker":"MRKR","cik":"0001094038","company_name":"Marker Therapeutics, Inc.","filed_at":"2024-12-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.644534+00:00","generated_at":"2026-05-29T00:55:05.655516+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Marker Therapeutics: 78% objective response in APOLLO study; raises $16.1M in private placement","bullets":["Phase 1 APOLLO: 78% of patients (7/9) achieved objective response; 44.4% complete response at first assessment.","MT-601 well tolerated; no ICANS observed, one Grade 1 CRS; no dose-limiting toxicities.","Private placement raises $16.1M gross proceeds; 5,031,250 shares at $3.20 with warrants at $4.03.","Proceeds to support clinical advancement of MT-601 in relapsed lymphoma after CAR-T failure.","New and existing investors: Blue Owl, NEA, and Aisling Capital participated in the financing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-130002","json":"https://secwatch.observer/filing/0001104659-24-130002.json","markdown":"https://secwatch.observer/filing/0001104659-24-130002.md","text":"https://secwatch.observer/filing/0001104659-24-130002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1094038/000110465924130002/0001104659-24-130002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1094038/000110465924130002/tm2431560d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T00:55:05.655516+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}